Utilized for gastroesophageal reflux disease to alleviate gastric acid production and manage esophageal healing.
Mechanism of Action
This medication irreversibly binds to the gastric hydrogen-potassium ATPase pump in parietal cells. By inhibiting this enzyme system, it effectively blocks the final step of acid secretion, reducing overall stomach acidity.
Route of Administration
Oral
Onset Time
1–3 hours
Duration
24–48 hours
Contraindications
Hypersensitivity to lansoprazole, Concurrent use of rilpivirine
Severe Adverse Events
Clostridium difficile-associated diarrhea, Bone fracture, Hypomagnesemia — requires immediate medical attention
Information related to Prevacid is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
